ASX Release | 7 October 2026 ASX:NXN | Nexsen Limited | ACN 655182497 1 Notice of AGM and Meeting Materials Nexsen Limited (ASX:NXN) (“Nexsen” or the “Company”), an emerging leader in rapid point-of-care diagnostics, advises that it will hold its 2026 Annual General...
Nexsen: Notice of AGM and Meeting Materials
Filed with ASX · · 25 pages · English
Summary by 6ix AI
Nexsen Limited has released a notice regarding its upcoming Annual General Meeting, scheduled for November at a specified location in Perth. The notice includes details about the meeting agenda, which covers resolutions such as the adoption of the Remuneration Report and the election of directors. Shareholders are encouraged to review the meeting materials and participate either in person or by proxy. This filing serves to inform shareholders about the meeting logistics and the items to be voted on during the AGM.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Nexsen
- Professor Shekhar Kumta appointed Executive Director
- Reinstatement to Quotation
- Proposed FlashDx joint venture builds on CE-marked GBS test
- Suspension from Quotation
- Clear pathway defined to optimise StrepSure
Later from Nexsen
- Quarterly Report - Q1 FY27
- ISO 13485 Certification brings StrepSure closer to market
- Co Secretary Appoint/Resign and Change of Registered Address
- Nexsen advances kidney diagnostics program
Follow Nexsen into a list and get an email when it puts out news.
Follow Nexsen